PharMEDium Services is expanding the recall issued on December 27, 2017 to include additional sterile drug products due to a lack of assurance of sterility.  Administration of a drug products intended to be sterile that is not sterile could result in serious infections that may be life-threatening.    The recall is being expanded because PharMEDium conducted  an extensive review of all commercially distributed product lots compounded in the Memphis location currently within their labeled...